Published in J Cardiovasc Transl Res on July 14, 2010
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov (2014) 1.61
Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes. PLoS One (2014) 1.10
Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases. Am J Physiol Regul Integr Comp Physiol (2013) 1.00
Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One (2012) 0.93
Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology. EPMA J (2013) 0.87
Gold nanoparticles - the theranostic challenge for PPPM: nanocardiology application. EPMA J (2013) 0.85
Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J Cardiovasc Transl Res (2011) 0.82
Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release. Langmuir (2012) 0.78
Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis. Int Ophthalmol (2013) 0.76
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Evidence for cardiomyocyte renewal in humans. Science (2009) 14.17
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
Polymeric system for dual growth factor delivery. Nat Biotechnol (2001) 7.20
Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol (2003) 6.57
New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues. J Chromatogr (1987) 6.17
Metal chelate affinity chromatography, a new approach to protein fractionation. Nature (1975) 5.83
Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev (1997) 5.73
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev (2007) 4.69
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov (2003) 4.58
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res (2004) 3.93
Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation (2005) 3.61
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol (2007) 3.05
Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation (2007) 2.99
Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest (2005) 2.80
Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A (2006) 2.75
Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol (2006) 2.48
New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Curr Top Med Chem (2006) 2.38
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail (2002) 2.18
Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation (2007) 2.07
Healing after myocardial infarction. Cardiovasc Res (2005) 2.05
Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater (2008) 2.05
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol (2007) 2.04
Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res (2010) 1.90
Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med (2007) 1.81
Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol (2009) 1.71
Cardiac regeneration. J Am Coll Cardiol (2006) 1.67
Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng (2007) 1.56
Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur J Cardiothorac Surg (2006) 1.54
Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr Pharm Des (2005) 1.53
Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. Bioconjug Chem (2005) 1.52
Control of self-assembling oligopeptide matrix formation through systematic variation of amino acid sequence. Biomaterials (2002) 1.52
Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol (2010) 1.40
Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci U S A (1998) 1.37
Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release (2001) 1.35
Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng (2007) 1.33
Biophysical aspects of using liposomes as delivery vehicles. Biosci Rep (2002) 1.33
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol Sci (2010) 1.22
Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation (2001) 1.19
Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release (2004) 1.19
Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. Bioconjug Chem (2008) 1.14
Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant (2009) 1.13
Polyketal microparticles: a new delivery vehicle for superoxide dismutase. Bioconjug Chem (2007) 1.12
Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des (2009) 1.10
ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction. Pharm Res (2005) 1.10
Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med (2010) 1.08
Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med (2006) 1.08
Kinase inhibitors: a new approach to rheumatoid arthritis treatment. Curr Opin Rheumatol (2010) 1.08
Antibody targeting of stem cells to infarcted myocardium. Stem Cells (2006) 1.07
Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug Chem (2006) 1.07
Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem (2003) 1.06
Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials (2009) 1.06
Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation (1987) 1.03
Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2). J Biomed Mater Res (2002) 1.02
Stem cell therapy in acute myocardial infarction: a review of clinical trials. Transl Res (2010) 1.00
Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium. J Control Release (2007) 0.99
A dual gold nanoparticle conjugate-based lateral flow assay (LFA) method for the analysis of troponin I. Biosens Bioelectron (2010) 0.98
Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium. J Biomed Mater Res B Appl Biomater (2008) 0.97
Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nat Med (1995) 0.97
The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials (2010) 0.97
The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury. Biomaterials (2009) 0.95
Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging (2004) 0.95
Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg (2003) 0.93
Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J Surg Res (2005) 0.92
Collagen-GAG scaffolds grafted onto myocardial infarcts in a rat model: a delivery vehicle for mesenchymal stem cells. Tissue Eng (2006) 0.91
Oxidative stress in congestive heart failure. Curr Cardiol Rep (2000) 0.91
Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating. JACC Cardiovasc Interv (2008) 0.90
Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail (2009) 0.89
Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction. Pharm Res (2007) 0.88
Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J Control Release (2009) 0.87
Targeting of Lin-Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardium. Blood Cells Mol Dis (2004) 0.86
A new biodegradable braided self-expandable PLGA prostatic stent: an experimental study in the rabbit. J Endourol (2008) 0.86
From stem cells and cadaveric matrix to engineered organs. Curr Opin Biotechnol (2009) 0.85
Polyketal microparticles for therapeutic delivery to the lung. Biomaterials (2009) 0.83
Surface functionalization of polyketal microparticles with nitrilotriacetic acid-nickel complexes for efficient protein capture and delivery. Biomaterials (2010) 0.83
ATP-loaded liposomes for treatment of myocardial ischemia. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.81
Carboxylated magnetic microbead-assisted fluoroimmunoassay for early biomarkers of acute myocardial infarction. Colloids Surf B Biointerfaces (2009) 0.80
Application of scaffold materials in tissue reconstruction in immunocompetent mammals: our experience and future requirements. Biomaterials (2007) 0.79
Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats. Circ J (2009) 0.79
Local delivery of basic fibroblast growth factor (bFGF) using adsorbed silyl-heparin, benzyl-bis(dimethylsilylmethyl)oxycarbamoyl-heparin. Bioconjug Chem (2002) 0.78
Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour. Biomaterials (2008) 0.78
Acid-degradable protein delivery vehicles based on metathesis chemistry. Biomacromolecules (2007) 0.78
Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization. Tex Heart Inst J (2009) 0.76
Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med (2007) 8.06
Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest (2005) 2.80
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation (2004) 2.11
Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol (2003) 2.09
Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater (2008) 2.05
Endothelial-cardiomyocyte interactions in cardiac development and repair. Annu Rev Physiol (2006) 1.68
Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol (2003) 1.41
A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro. Acta Biomater (2012) 1.27
Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ Res (2004) 1.09
Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury. Stem Cells Dev (2013) 0.97
The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury. Biomaterials (2009) 0.95
Identification of novel tissue-specific genes by analysis of microarray databases: a human and mouse model. PLoS One (2013) 0.95
Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One (2012) 0.93
Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells. Stem Cell Res Ther (2013) 0.93
Cellular encapsulation enhances cardiac repair. J Am Heart Assoc (2013) 0.92
Engineering insulin-like growth factor-1 for local delivery. FASEB J (2008) 0.92
Effect of feeding nitrite, ascorbate, hemin, and omeprazole on excretion of fecal total apparent N-nitroso compounds in mice. Chem Res Toxicol (2008) 0.90
N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing. J Cardiovasc Transl Res (2011) 0.86
Temporal effects of catalase overexpression on healing after myocardial infarction. Circ Heart Fail (2010) 0.86
Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction. Biomaterials (2013) 0.84
Age- and chamber-specific differences in oxidative stress after ischemic injury. Pediatr Cardiol (2011) 0.83
Surface functionalization of polyketal microparticles with nitrilotriacetic acid-nickel complexes for efficient protein capture and delivery. Biomaterials (2010) 0.83
Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury. Biomaterials (2012) 0.82
Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review. Interface Focus (2012) 0.82
Induction of pluripotency in bone marrow mononuclear cells via polyketal nanoparticle-mediated delivery of mature microRNAs. Biomaterials (2013) 0.80
Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction. Biomaterials (2013) 0.79
Characterization of superoxide dismutases in cardiac progenitor cells demonstrates a critical role for manganese superoxide dismutase. Stem Cells Dev (2012) 0.78
Isolation and expansion of c-kit-positive cardiac progenitor cells by magnetic cell sorting. Methods Mol Biol (2014) 0.77
Decreased MCF-7 breast cancer cell proliferation by serum from a selected line of beef cattle. Anticancer Res (2005) 0.75
Detection of two nucleotide substitutions and putative promoters in the 5' flanking region of the ovine IGF-I gene. J Appl Genet (2005) 0.75
Self-assembling peptide-based delivery of therapeutics for myocardial infarction. Methods Mol Biol (2014) 0.75
Spatiotemporal control of cell fate and cardiac differentiation. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Dendrimeric bowties featuring hemispheric-selective decoration of ligands for microRNA-based therapy. Biomacromolecules (2012) 0.75